Tumour-associated trypsin inhibitor (TATI) in ovarian cancer
Authors:
Open Access
- 1 March 1988
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 57 (3) , 304-307
Abstract
Tumour-associated trypsin inhibitor (TATI) is a 6 kD peptide isolated from the urine of a patient with ovarian cancer. Increased urinary excretion of TATI has earlier been observed in patients with gynaecological malignancies. The value of TATI in urine and serum as a marker for ovarian cancer was studied in 102 patients. Preoperatively urine TATI was elevated in 55% (18/33) and serum TATI in 27% (12/45) of the patients. In patients with mucinous tumours, elevated preoperative levels of TATI were observed in 6 out of 10 patients, while CA 125 was elevated in 4 and CEA in one of the cases. When assay of TATI was used to predict presence of disease before second-look surgery of 48 patients, the sensitivity and specificity of serum TATI was 19% and 91%, and that of urine TATI 42% and 76%, respectively. Rising TATI levels were observed in progressive disease, whereas regressive disease was not as often associated with falling levels. Serum TATI was elevated in 45% (144/318) and urine TATI in 57% (73/171) of samples from patients with clinical evidence of disease. The TATI assay was found to be of potential value in the management of patients with mucinous ovarian cancer, but in patients with non-mucinous ovarian cancer it did not provide information additional to that obtained from assay of ovarian cancer marker CA 125 alone.Keywords
This publication has 16 references indexed in Scilit:
- Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEABritish Journal of Cancer, 1987
- CA 125 surveillance and second-look laparotomy in ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- POSTOPERATIVE ELEVATION OF SERUM PANCREATIC SECRETORY TRYPSIN-INHIBITOR1985
- Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenAmerican Journal of Obstetrics and Gynecology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Excretion of a tumor‐associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancyInternational Journal of Cancer, 1983
- Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer.Journal of Biological Chemistry, 1982
- Immunochemical demonstration of an ovarian cancer‐associated urinary peptideInternational Journal of Cancer, 1982
- Reporting results of cancer treatmentCancer, 1981
- A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.1975